NCT00717704View on ClinicalTrials.gov

Solid Tumors Using Ixabepilone and Dasatinib

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Solid Tumor
Interventions
DRUG

ixabepilone

by vein once every 3 weeks

DRUG

Dasatinib

by mouth once daily

Trial Locations (1)

20010

Washington Cancer Institute, Washington D.C.

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Medstar Health Research Institute

OTHER